Skip to main navigation
Skip to search
Skip to main content
University of Plymouth Home
Help & FAQ
Home
Researchers
Research units
Research outputs
Projects
Theses
Datasets
Activities
Prizes
Media stories
Search by expertise, name or affiliation
Valproate MHRA Guidance: Limitations and Opportunities
Lance Watkins
, Hannah Cock
, Heather Angus-Leppan
, Kim Morley
, Mike Wilcock
,
Rohit Shankar
*
*
Corresponding author for this work
Peninsula Medical School
Kingston University and St George’s
St George's Hospital
Royal Free London NHS Foundation Trust
University College London
University of Hertfordshire
Hampshire Hospitals NHS Foundation Trust
Royal Cornwall Hospitals NHS Trust
Research output
:
Contribution to journal
›
Article
›
peer-review
16
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Valproate MHRA Guidance: Limitations and Opportunities'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Medicine
100%
Sodium Valproate
100%
Drug Therapy
50%
Decision Making
25%
Informed Consent
25%
Epileptic Seizure
25%
Cognitive Function
25%
Vulnerable Population
25%
Nursing and Health Professions
Intellectual Impairment
100%
Valproic Acid
100%
Drug Therapy
50%
Vulnerable Population
25%
Pharmacology, Toxicology and Pharmaceutical Science
Intellectual Impairment
100%
Sodium Valproate
100%
Psychology
Intellectual Disability
100%
Decision Making
25%
Informed Consent
25%
Cognitive Function
25%